medigraphic.com
SPANISH

Cirugía Cardiaca en México

ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 1

<< Back Next >>

Cir Card Mex 2021; 6 (1)

Postoperative adverse events in patients with coronary artery bypass grafting for left main coronary stenosis

Cázares-Pérez A, Urías Puentes A, González-Villaseñor JJ, Vega-Hernández R, Quezada-Angulo R, Castro-Roblin LE
Full text How to cite this article

Language: English
References: 21
Page: 3-9
PDF size: 194.33 Kb.


Key words:

Left main coronary stenosis, Coronary artery bypass grafting, Surgical complications.

ABSTRACT

Objective. To determine the immediate adverse postoperative events in patients with left main coronary stenosis submitted to coronary artery bypass grafting. Material. This was an observational, transverse analytical and retrospective study. Two hundred and two patients with significant left main coronary stenosis submitted to coronary artery bypass grafting in in our institution between January 2018 to December 2018 were included, and postoperative complications were documented. Results. Of the 232 patients 80.2% were men, with an average age of 64 years; diabetes mellitus 52.6%, dyslipidemia 74.6% and chronic kidney failure 4.7%. The main postoperative complications were renal failure 18.9%, atrial fibrillation 11.3% and global mortality 2.9%. Factors associated with complication were female sex with OR=2.89 (95% CI 1.4-5.6, p = 0.002), age of 64.43 ± 8.87 p = 0.019, dyslipidemia OR 2.17 (95% CI 1.15-4.11, p = 0.016), and chronic kidney failure OR 15 (95% CI 1.9- 120, p = 0.001). Complicated patients required mechanical ventilation for 19.4 hours, inotropic use for 38.34 hours and intensive care stay of 74.66 hours, (p=0.01). Conclusions. Factors associated with complications with statistical significance were female sex, age, history of dyslipidemia, chronic kidney disease Chronic renal failure was the most important factor associated with complications. The presence of a complication was associated with a longer time in mechanical ventilation, use of inotropic and intensive care stay.


REFERENCES

  1. Wang L, Qian X, Wang M, Tang X, Ao H. Which factor is the most effective one inmetabolic Sydrome on the outcomes after coronary artery bypass graft surgery? Acohort study of 5 Years. J Cardiothorac Surg 2018;13(1):1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29301583

  2. Mehaffey JH, Hawkins RB, Byler M, Charles EJ, Fonner C, Kron I, et al. Costof individual complications following coronary artery bypass grafting. J ThoracCardiovasc Surg 2018;155(3):875-882.e1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29248284

  3. Fanari Z, Elliott D, Russo CA, Kolm P, Weintraub WS. Predicting readmissionrisk following coronary artery bypass surgery at the time of admission. CardiovascRevascularization Med. 2017;18(2):95–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27866747

  4. Hawkes AL, Nowak M, Bidstrup B, Speare R. Outcomes of coronary artery bypassgraft surgery. Vasc Health Risk Manag 2006;2(4):477–84. Available from:http://www.ncbi.nlm.nih.gov/pubmed/17323602

  5. Scheier MF, Matthews KA, Owens JF, Schulz R, Bridges MW, Magovern GJ, etal. Optimism and rehospitalization after coronary artery bypass graft surgery. ArchIntern Med. 1999;159(8):829–35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10219928

  6. Chang M, Lee CW, Ahn J-M, Cavalcante R, Sotomi Y, Onuma Y, et al. Coronaryartery bypass graft surgery versus drug-eluting stent implantation for high-surgical-risk patients with left main or multivessel coronary artery disease. Eur JCardio-Thoracic Surg. 2017;51(5):943–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28329291

  7. Hussein Kamel AT, Hassouna A, El-Hamid HE-DAA, Hikal TS. Major adversecardiac events after first time elective isolated coronary artery bypass grafting: Aretrospective cohort study. J Egypt Soc Cardio-Thoracic Surg 2018;26(4):237–44. Available from: https://www.sciencedirect.com/science/article/pii/S1110578X18301214

  8. Head SJ, Kieser TM, Falk V, Huysmans HA, Kappetein AP. Coronary artery bypass grafting: Part 1--the evolution over the first 50 years. Eur HeartJ. 2013;34(37):2862–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24086085

  9. Montrief T, Koyfman A, Long B. Coronary artery bypass graft surgery complications:A review for emergency clinicians. Am J Emerg Med. 2018;36(12):2289–97. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30217621

  10. Greason KL, Schaff H V. Myocardial Revascularization by Coronary ArterialBypass Graft: Past, Present, and Future. Curr Probl Cardiol. 2011;36(9):325–68.Available from: http://www.ncbi.nlm.nih.gov/pubmed/21821188

  11. Eyuboglu M. Preoperative diagnosis and postoperative prognosis in patientsundergoing coronary artery bypass graft surgery. Am Heart J. 2016 J;171(1):e9.Available from: http://www.ncbi.nlm.nih.gov/pubmed/26699611

  12. Mawhinney JA, Mounsey CA, Taggart DP. The potential role of external venoussupports in coronary artery bypass graft surgery†. Eur J Cardio-ThoracicSurg. 2018;53(6):1127–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29228235.

  13. Kieser TM, Taggart DP. Current status of intra-operative graft assessment:Should it be the standard of care for coronary artery bypass graft surgery? JCard Surg. 2018;33(5):219–28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29570863

  14. Rocha EAV. Fifty Years of Coronary Artery Bypass Graft Surgery. Brazilian JCardiovasc Surg. 2017;32(4):II–III. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28977193

  15. Freundlich RE, Maile MD, Hajjar MM, Habib JR, Jewell ES, Schwann T, et al.Years of Life Lost After Complications of Coronary Artery Bypass Operations.Ann Thorac Surg. 2017;103(6):1893–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27938887

  16. Kieser TM. Graft quality verification in coronary artery bypass graft surgery. CurrOpin Cardiol. 2017;32(6):722–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28806185

  17. Slottosch I, Liakopoulos O, Kuhn E, Deppe A-C, Scherner M, Mader N, et al.Outcome after coronary bypass grafting for coronary complications following coronaryangiography. J Surg Res. 2017;210:69–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28457342

  18. Aguilar-Salinas C. Comentarios a la ENSANUT 2012. Salud Publica Mex.2013;55:S347–50. Available from: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342013000800035

  19. Aldea GS, Bakaeen FG, Pal J, Fremes S, Head SJ, Sabik J, et al. The Society ofThoracic Surgeons Clinical Practice Guidelines on Arterial Conduits for CoronaryArtery Bypass Grafting. Ann Thorac Surg. 2016;101(2):801–9. Available from:http://www.ncbi.nlm.nih.gov/pubmed/26680310

  20. Organización Mundial de la Salud. Enfermedades no transmisibles. 2018. Availablefrom: https://www.who.int/es/news-room/fact-sheets/detail/noncommunicable-diseases

  21. Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, BiryukovS, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters ofrisks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659–724. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27733284




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cir Card Mex. 2021;6